dipyridamole has been researched along with Preterm Birth in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Excerpt | Relevance | Reference |
---|---|---|
"Spontaneous preterm birth is an important cause of neonatal mortality and morbidity." | 2.55 | Antiplatelet Agents and the Prevention of Spontaneous Preterm Birth: A Systematic Review and Meta-analysis. ( Askie, LA; Mol, BWJ; Oudijk, MA; van Vliet, EOG, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
van Vliet, EOG | 1 |
Askie, LA | 1 |
Mol, BWJ | 1 |
Oudijk, MA | 1 |
1 review available for dipyridamole and Preterm Birth
Article | Year |
---|---|
Antiplatelet Agents and the Prevention of Spontaneous Preterm Birth: A Systematic Review and Meta-analysis.
Topics: Adult; Aspirin; Dipyridamole; Female; Gestational Age; Humans; Logistic Models; Platelet Aggregation | 2017 |